News
Zacks Investment Research on MSN23h
Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track TagSanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, SAR446597, for the treatment of geographic atrophy (GA) due to age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback